Predictors and consequences of anaemia among antiretroviral-nave HIV-infected and HIV-uninfected children in Tanzania

Public Health Nutrition

Volumn 13, Issue 2, 2010, Pages 289-296

  Chatterjee, Anirban ^a   Bosch, Ronald J ^a   Kupka, Roland ^a   Hunter, David J ^a   Msamanga, Gernard I ^b   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Anaemia; Child mortality; HIV; Malaria; Sub Saharan Africa

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT;

ADULT; ANEMIA; ARTICLE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE TRANSMISSION; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; IRON DEFICIENCY ANEMIA; MALARIA; MORTALITY; NEWBORN; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; TANZANIA; VERTICAL TRANSMISSION;

ADULT; ANEMIA; ANEMIA, IRON-DEFICIENCY; ANTI-RETROVIRAL AGENTS; ANTIMALARIALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALARIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TANZANIA;

EID: 77449118385     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980009990802     Document Type: Article

References (41)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S & Murray CJ; Comparative Risk Assessment Collaborating Group (2002) Selected major risk factors and global and regional burden of disease. Lancet 360, 1347-1360.
2. United Nations Administrative Committee on Coordination, Sub-committee on Nutrition (2000) Fourth Report on the World Nutrition Situation: Nutrition Throughout the Life-cycle. Geneva: UN Press.
3. Belperio PS & Rhew DC (2004) Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 116, Suppl. 7A, 27S-43S.
4. DeMaeyer E & Adiels-Tegman M (1985) The prevalence of anemia in the world. World Health Stat Q 38, 302-316.
5. Stoltzfus R, Mullany L & Black RE (2004) Iron deficiency anemia. In Comparative Quantification of Health Risks: The Global and Regional Burden of Disease due to 25 Selected Major Risk Factors, pp. 163-209 [M Ezzati, AD Lopez, A Rodgers and CJL Murray, editors]. Geneva: WHO.
6. Stoltzfus RJ & Dreyfus MJ (1998) Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia. Washington, DC: ILSI Press.
7. Lozoff B, Brittenham GM, Wolf AW, McClish DK, Kuhnert PM, Jimenez E, Jimenez R, Mora LA, Gomez I & Krauskoph D (1987) Iron deficiency anemia and iron therapy effects on infant development test performance. Pediatrics 79, 981-985.
8. Beard J (2001) Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 131, 2 Suppl., 568S-580S.
9. Chandra RK (1973) Reduced bactericidal activity of polymorphs in iron deficiency. Arch Dis Child 48, 864-867.
10. Bhaskaram P & Reddy V (1975) Cell mediated immunity in iron-and vitamin-deficient children. Br Med J iii, 522-524.
11. Mocroft A, Kirk O, Barton S, Dietrich M, Proenca R, Colebunders R, Pradier C, dArminio Monforte A, Ledergerber B & Lundgren JD (1999) Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS 13, 943-950.
12. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ & Fawzi WW (2005) Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immun Defic Syndr 40, 219-225.
13. Fawzi WW, Msamanga GI, Spiegelman D et al. (1998) Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 351, 1477-1482.
14. Lohman TG, Roche AF & Martorell R (editors) (1988) Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Publishing.
15. Diggle P, Liang K & Zeger S (1994) Analysis of Longitudinal Data. London: Oxford University Press.
16. Miettinen OS (1985) Theoretical Epidemiology. New York: John Wiley and Sons.
17. Blanche S, Rouzioux C, Moscato ML et al. (1989) A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N Engl J Med 320, 1643-1648.
18. Blanche S, Mayaux MJ, Rouzioux C et al. (1994) Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 330, 308-312.
19. Lambert G, Thea DM, Pliner V et al. (1997) Effect of maternal CD41 cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group. J Pediatr 130, 890-897.
20. Abrams EJ, Wiener J, Carter R, Kuhn L, Palumbo P, Nesheim S, Lee F, Vink P & Bulterys M; Perinatal AIDS Collaborative Transmission Study (PACTS) Group (2003) Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children. AIDS 17, 867-877.
21. Chearskul S, Chotpitayasunondh T, Simonds RJ et al.; Bangkok Collaborative Perinatal HIV Transmission Study Group (2002) Survival, disease manifestation and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics 110, 25-30.
22. Chatterjee A, Bosch RJ, Hunter DJ, Fataki MR, Msamanga GI & Fawzi WW (2007) Maternal disease stage and child undernutrition in relation to mortality among children born to HIV-infected women in Tanzania. J Acquir Immun Defic Syndr 46, 599-606.
23. Widdowson EM & Spray CM (1951) Chemical development in utero. Arch Dis Child 26, 205-214.
24. Singla PN, Gupta VK & Agarwal KN (1985) Storage iron in human fetal organs. Acta Pediatr Scand 74, 701-706.
25. Burnstein Y, Rashbaum WK, Hatch WC, Calvelli T, Golodner M, Soeiro R & Lyman WD (1992) Alterations in human fetal erythropoiesis are associated with maternal HIV infection. Pediatr Res 32, 155-159.
26. Reed SC, Wirima JJ & Stekeete RW (1994) Risk factors for anemia in young children in rural Malawi. Am J Trop Med Hyg 51, 170-174.
27. Cornet M, Le Hesran JY, Fievet N, Cot M, Personne P, Gounoue R, Beyeme M & Deloron P (1998) Prevalence of and risk factors for anemia in young children in southern Cameroon. Am J Trop Med Hyg 58, 606-611.
28. Adewuyi J & Chitsike I (1994) Hematologic features of the human immunodeficiency virus (HIV) infection in black children in Harare. Cent Afr J Med 40, 333-336.
29. Shaffer N, Hedberg K, Davachi F, Lyamba B, Breman JG, Masisa OS, Behets F, Hightower A & Nguyen-Dinh P (1990) Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. AIDS 4, 1231-1236.
30. Totin D, Ndugwa C, Mmiro F, Perry RT, Jackson JB & Semba RD (2002) Iron deficiency anemia is highly prevalent among human immunodeficiency virus-infected and uninfected infants in Uganda. J Nutr 132, 423-429.
31. Eley BS, Sive AA, Shuttleworth M & Hussey GD (2002) A prospective, cross-sectional study of anemia and peripheral iron status in antiretroviral naïve, HIV-infected children in Cape Town, South Africa. BMC Infect Dis 2, 3.
32. Villamor E, Mbise R, Spiegelman D, Ndossi G & Fazwi WW (2000) Vitamin A supplementation and other predictors of anemia among children from Dar es Salaam, Tanzania. Am J Trop Med Hyg 62, 590-597.
33. Semba RD & Gray GE (2001) The pathogenesis of anemia during human immunodeficiency virus infection. J Invest Med 49, 225-239.
34. Clark TD,Mmiro F, Ndugwa C, Perry RT, Jackson JB,MelikianG & Semba RD (2002) Risk factors and cumulative incidence of anaemia among human immunodeficiency virusinfected children in Uganda. Ann Trop Pediatr 22, 11-17.
35. Ellaurie M, Burns ER & Rubinstein M (1990) Hematologic manifestations in pediatric HIV infection: severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol 12, 449-453.
36. Cross Continents Collaborative for Kids (3Cs4kids) Analysis and Writing Committee (2008) Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 22, 97-105.
37. Sazawal S, Black RE, Ramsan M et al. (2006) Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: communitybased, randomized, placebo-controlled trial. Lancet 367, 133-143. (Pubitemid 43077129)
38. Tielsch JM, Khatry SK, Stotlzfus RJ, Katz J, LeClerq SC, Adhikari R, Mullany LC, Shresta S & Black RE (2006) Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based cluster-randomized, placebo-controlled trial. Lancet 367, 144-152.
39. Pinkerton PH, Spence I, Ogilvie JC, Ronald WA, Marchant P & Ray PK (1970) An assessment of the Coulter counter model S. J Clin Pathol 23, 68-76.
40. Massawe SN, Urassa EN, Mmari M, Ronquist G, Lindmark G & Nystrom L (1999) The complexity of pregnancy anemia in Dar-es-Salaam. Gynecol Obstet Invest 47, 76-82.
41. World Health Organization/Joint United Nations Programme on HIV/AIDS/UNICEF (2008) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2008. Geneva: WHO.